CA
XBI icon

Calton & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Calton & Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Sell
1,393
-3,850
-73% -$520K 0.03% 388
2026
Q1 		$670K Sell
5,243
-198
-4% -$24.7K 0.1% 194
2025
Q4 		$663K Buy
5,441
+201
+4% +$23K 0.1% 201
2025
Q3 		$525K Sell
5,240
-193
-4% -$17.4K 0.08% 229
2025
Q2 		$451K Sell
5,433
-229
-4% -$18.3K 0.08% 216
2025
Q1 		$459K Buy
5,662
+175
+3% +$15.6K 0.1% 181
2024
Q4 		$494K Buy
+5,487
New +$532K 0.22% 105
2024
Q3 		– Sell
-5,527
Closed -$512K – 281
2024
Q2 		$512K Sell
5,527
-598
-10% -$53.6K 0.26% 89
2024
Q1 		$581K Buy
6,125
+34
+0.6% +$3.15K 0.28% 84
2023
Q4 		$544K Buy
+6,091
New +$452K 0.22% 102
2023
Q3 		– Sell
-6,085
Closed -$506K – 260
2023
Q2 		$506K Buy
6,085
+135
+2% +$11.3K 0.24% 105
2023
Q1 		$453K Buy
5,950
+40
+0.7% +$3.32K 0.21% 108
2022
Q4 		$491K Buy
5,910
+3,045
+106% +$247K 0.19% 129
2022
Q3 		$227K Sell
2,865
-2
-0.1% -$169 0.13% 180
2022
Q2 		$212K Buy
+2,867
New +$215K 0.12% 205
2018
Q3 		– Sell
-2,117
Closed -$202K – 315
2018
Q2 		$202K Buy
+2,117
New +$195K 0.06% 267
2018
Q1 		– Sell
-1,651
Closed -$158K – 1287
2017
Q4 		$158K Buy
+1,651
New +$138K 0.04% 390

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Calton & Associates's XBI Position: Q2 2026 in Review

Calton & Associates reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 73% in Q2 2026, selling an estimated $520K and leaving 1,393 shares worth $221K. The position accounts for 0.03% of the portfolio, ranked #388.

Calton & Associates first reported a position in XBI in Q4 2017 and has held it in 17 quarters since. The position peaked at $670K in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Calton & Associates held 1,393 shares of State Street SPDR S&P Biotech ETF worth $221K as of Q2 2026.
  • Calton & Associates sold 3,850 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $520K.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Calton & Associates's portfolio in Q2 2026, its #388 holding.
  • Calton & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 17 quarters since.
  • Calton & Associates's State Street SPDR S&P Biotech ETF position peaked at $670K in Q1 2026.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.